BioSig Technologies, Inc. announces its intention to offer shares of common stock in a public offering.
The offering is underwritten and subject to market conditions.
Proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
Offer Details
Shares of common stock or pre-funded warrants will be offered by BioSig Technologies, Inc.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
Registration Statement
The offering is made under a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
- BioSig Technologies aims to use the proceeds for strategic investments, including the purchase of gold bullion.
- The involvement of Clear Street and Needham & Company as book-running managers enhances the credibility of the offering.
The proposed public offering by BioSig Technologies Inc. signifies a strategic move to raise capital for key business initiatives.